SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000912057-00-050231
Filing Date
2000-11-15
Accepted
2000-11-15 00:00:00
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A a2031159zsc13da.txt SC 13D/A 30760
2 EXHIBIT 1 a2031159zex-1.txt EX-1 3362
  Complete submission text file 0000912057-00-050231.txt   36492
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Subject) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-37205 | Film No.: 768661
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GENZYME TRANSGENICS CORP (Filed by) CIK: 0000904973 (see all company filings)

IRS No.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0103
SIC: 2836 Biological Products, (No Diagnostic Substances)